Cover Image


OTC Pharmaceuticals Market in Latin America 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 294981
出版日期 內容資訊 英文 46 Pages
Back to Top
南美的成藥市場 OTC Pharmaceuticals Market in Latin America 2014-2018
出版日期: 2014年01月17日 內容資訊: 英文 46 Pages



第1章 摘要整理

第2章 簡稱集

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模及預測
  • 波特的五力分析

第7章 各產品市場區隔

第8章 購買標準

第9章 市場成長要素

第10章 成長要素與其影響

第11章 市場課題

第12章 成長要素與課題的影響

第13章 市場趨勢

第14章 市場趨勢與其影響

第15章 業者情勢

  • 競爭模式
  • 其他卓越的供應商

第16章 主要供應商分析

  • Bayer HealthCare AG
  • EMS S.A.
  • Hypermarcas S.A
  • Novartis AG

第17章 相關報告


Product Code: IRTNTR3216

TechNavio's analysts forecast the OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin America has also been witnessing the some key increased outsourcing of drug development activities. However, the stringent regulations are expected to pose a challenge to the growth of this market.

TechNavio's report, the OTC Pharmaceuticals Market in Latin America Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the OTC Pharmaceuticals Market in Latin America market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG.

Other vendors mentioned in the report are Boehringer Ingelheim GmbH., Genomma Lab Internacional SAB., GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

Key questions answered in this report:

  • What will the market size be in 2018 and what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Products

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

  • 15.1. Competitive Scenario
    • 15.1.1. Key News
    • 15.1.2. Major Vendors
  • 15.2. Other Prominent Vendors

16. Key Vendor Analysis

  • 16.1. Bayer HealthCare AG
    • 16.1.1. Business Overview
    • 16.1.2. Business Segmentation
    • 16.1.3. Key Information
    • 16.1.4. SWOT Analysis
  • 16.2. EMS S.A.
    • 16.2.1. Business Overview
    • 16.2.2. Business Segmentation
    • 16.2.3. Key Information
    • 16.2.4. SWOT Analysis
  • 16.3. Hypermarcas S.A.
    • 16.3.1. Business Overview
    • 16.3.2. Business Segmentation
    • 16.3.3. Key Information
    • 16.3.4. SWOT Analysis
  • 16.4. Novartis AG
    • 16.4.1. Business Overview
    • 16.4.2. Business Segmentation
    • 16.4.3. Key Information
    • 16.4.4. SWOT Analysis

17. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: OTC Pharmaceuticals Market in Latin America 2013-2018 (US$ billion)
  • Exhibit 3: OTC Pharmaceuticals Market in Latin America by Product Segmentation
  • Exhibit 4: OTC Pharmaceuticals Market in Latin America Segmentation 2013
  • Exhibit 5: Business Segmentation of Bayer HealthCare AG
  • Exhibit 6: Business Segmentation of EMS S.A.
  • Exhibit 7: Business Segmentation of Hypermarcas S.A.
  • Exhibit 8: Business Segmentation of Novartis AG
Back to Top